A multicenter trial of pribedil as early adjunct treatment for Parkinson's disease: Pribedil International Study Group | Charles Explorer

A multicenter trial of pribedil as early adjunct treatment for Parkinson's disease: Pribedil International Study Group

Publikace

Abstrakt

Parkinson's disease, Pribedil

Osoby